Previous studies have reported elevated levels of heterogeneous nuclear ribonucleoproteins C1/C2 (HNRNPC) in some cancer cells, while HNRNPC knockdown resulted in significant arrest of cell proliferation and tumour growth in breast cancer.12 The gene discussed is HNRNPC; the disease is breast carcinoma.